by Brenda Watson | Aug 31, 2012 | General
In 2005 the FDA banned the use of a particular broad-spectrum (meaning effective against a broad range of microbes) antibiotic class—the fluoroquinolones—due to an alarming increase in the rate of resistance to Campylobacter bacteria. Yet, “In recent years, we’ve seen...
